Marshall Richard Peter
SEC Form 4 insider trading activity
Marshall Richard Peter has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, Marshall Richard Peter is listed as Director at Serina Therapeutics, Inc. Inside the rolling window, Marshall Richard Peter reported 1 open-market purchase totaling $20K in SER and no open-market sales.
Companies traded
Other insiders at SER
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Marshall Richard Peter made?
Marshall Richard Peter has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Marshall Richard Peter trade?
Marshall Richard Peter has filed SEC Form 4 disclosures for 1 company, including SER.
When was Marshall Richard Peter's most recent SEC Form 4 filing?
Marshall Richard Peter's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is Marshall Richard Peter's total buy and sell value in the current window?
Inside the rolling retention window, Marshall Richard Peter bought $20K and sold $0 based on SEC Form 4 filings.
What was Marshall Richard Peter's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,183 SER shares on 2026-05-19, worth $20K, per SEC Form 4 filings.